(Q37235971)

19 August 2017

1 reference

title

Metastatic bone pain: treatment options with an emphasis on bisphosphonates (English)

1 reference

19 August 2017

Roger von Moos

1

1 reference

19 August 2017

Florian Strasser

series ordinal

2

1 reference

19 August 2017

Silke Gillessen

series ordinal

3

1 reference

19 August 2017

Kathrin Zaugg

series ordinal

4

1 reference

19 August 2017

publication date

6 August 2008

1 reference

Supportive Care in Cancer

19 August 2017

published in

1 reference

19 August 2017

volume

16

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

1105-1115

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-008-0487-0

19 August 2017

exact match

0 references

cites work

Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians

1 reference

https://api.crossref.org/works/10.1007%2FS00520-008-0487-0

The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-008-0487-0

Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-008-0487-0

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-008-0487-0

Malignant bone pain: pathophysiology and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-008-0487-0

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-008-0487-0

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases

21 January 2018

1 reference

12 December 2020

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial

1 reference

12 December 2020

Practice guidelines for transdermal opioids in malignant pain

1 reference

12 December 2020

Bisphosphonates for breast cancer

1 reference

12 December 2020

Clinical application of the World Health Organization analgesic ladder.

1 reference

12 December 2020

Pain control by ionizing radiation of bone metastasis

1 reference

12 December 2020

Antiepileptic drugs in the treatment of neuropathic pain

1 reference

12 December 2020

Scoring the effect of radiotherapy for painful bone metastases

1 reference

12 December 2020

Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

1 reference

12 December 2020

Usefulness of bone formation markers in breast cancer.

1 reference

12 December 2020

Percutaneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: A prospective study using quality-of-life assessment.

1 reference

12 December 2020

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline

1 reference

12 December 2020

Preclinical perspectives on bisphosphonate renal safety

1 reference

12 December 2020

Treatment of painful osteoporotic or traumatic vertebral compression fractures by percutaneous vertebral augmentation procedures: a nonrandomized comparison between vertebroplasty and kyphoplasty.

1 reference

12 December 2020

A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

1 reference

12 December 2020

Therapy of metastatic bone pain

1 reference

12 December 2020

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

1 reference

12 December 2020

Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study

1 reference

12 December 2020

Controversies in pharmacotherapy of pain management.

1 reference

12 December 2020

Balloon kyphoplasty for the treatment of pathological fractures in the thoracic and lumbar spine caused by metastasis: one-year follow-up.

1 reference

12 December 2020

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

Physiological bases of bone regeneration II. The remodeling process.

1 reference

12 December 2020

Bone imaging in metastatic breast cancer

1 reference

12 December 2020

Clodronate: a review of its use in breast cancer

1 reference

12 December 2020

A review of local radiotherapy in the treatment of bone metastases and cord compression

1 reference

12 December 2020

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

1 reference

12 December 2020

Pathophysiology of bone cancer pain.

1 reference

12 December 2020

Biology of bone metastases: causes and consequences.

1 reference

12 December 2020

Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity

1 reference

12 December 2020

Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases

1 reference

12 December 2020

Osteonecrosis of the jaw associated with pamidronate therapy

1 reference

12 December 2020

Bisphosphonates for cancer patients: why, how, and when?

1 reference

12 December 2020

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid

1 reference

12 December 2020

Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma

1 reference

12 December 2020

Acrylic bone cements: mechanical and physical properties

1 reference

12 December 2020

Bisphosphonates for the relief of pain secondary to bone metastases.

1 reference

12 December 2020

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.

1 reference

12 December 2020

Healing focal "flare" phenomenon after radiotherapy in a bone metastasis from bladder cancer

1 reference

12 December 2020

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

1 reference

12 December 2020

Oral clodronate in breast cancer patients with bone metastases: a randomized study.

1 reference

12 December 2020

Bisphosphonates and metastatic breast carcinoma

1 reference

12 December 2020

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

12 December 2020

Treatment of painful compression vertebral fractures with vertebroplasty: results and complications.

1 reference

12 December 2020

Pain management in cancer patients with bone metastases remains a challenge

1 reference

12 December 2020

Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial

1 reference

12 December 2020

Bisphosphonates for metastatic bone pain

1 reference

12 December 2020

Use of strong opioids in advanced cancer pain: a randomized trial.

1 reference

12 December 2020

Bisphosphonates in the prevention of bone metastases: current evidence

1 reference

12 December 2020

PMMA to stabilize bone and deliver antineoplastic and antiresorptive agents

1 reference

12 December 2020

Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer

1 reference

12 December 2020

Maintained pain reduction in five patients with multiple myeloma 12 months after treatment of the involved cervical vertebrae with vertebroplasty.

1 reference

12 December 2020

The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer

1 reference

12 December 2020

Bone metastases in breast cancer

1 reference

12 December 2020

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

12 December 2020

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

12 December 2020

Bisphosphonates and radiation therapy for palliation of metastatic bone disease

1 reference

12 December 2020

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial

1 reference

12 December 2020

Radioisotopes for metastatic bone pain

1 reference

12 December 2020

Promoting science in a pragmatic world: not (yet) time for partial opioid rotation

1 reference

12 December 2020

Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial

1 reference

12 December 2020

High dose pamidronate: clinical and biochemical effects in metastatic bone disease.

1 reference

12 December 2020

Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

1 reference

12 December 2020

Radiotherapy for the palliation of painful bone metastases.

1 reference

12 December 2020

Epidemiology of cancer pain and factors influencing poor pain control

1 reference

12 December 2020

A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases

1 reference

12 December 2020

The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer

1 reference

12 December 2020

The role of bisphosphonates in hormone-refractory prostate cancer

1 reference

12 December 2020

The use of bisphosphonates in patients with breast cancer

1 reference

12 December 2020

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

1 reference

12 December 2020

Bone metastases: approaches to management

1 reference

12 December 2020

Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer

1 reference

12 December 2020

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

12 December 2020

Biology of bone cancer pain

1 reference

12 December 2020

The use of palliative radiotherapy in the management of breast cancer

1 reference

12 December 2020

Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease

1 reference

12 December 2020

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

1 reference

12 December 2020

Malignant bone pain: pathophysiology and treatment

1 reference

12 December 2020

Bisphosphonates in the treatment of metastatic breast cancer

1 reference

12 December 2020

Bisphosphonates: clinical experience

1 reference

12 December 2020

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

12 December 2020

Analysis of skeletal-related events in breast cancer and response to therapy

1 reference

12 December 2020

Renal Failure with the Use of Zoledronic Acid

1 reference

12 December 2020

Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials.

1 reference

12 December 2020

Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases

1 reference

12 December 2020

Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy

1 reference

12 December 2020

Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

1 reference

12 December 2020

Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain

1 reference

12 December 2020

10.1007/S00520-008-0487-0

Identifiers

DOI

1 reference

19 August 2017

1 reference